Work

The transglutaminase 2 gene ( TGM2 ), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer

Year: 2008

Type: article

Source: Carcinogenesis

DOI: 10.1093/carcin/bgm280

Authors: Lingbao Ai, Wan-Ju Kim, Berna Demircan, Lisa M. Dyer, Kevin J. Bray, Ryan R. Skehan, Nicole A. Massoll, Kevin D. Brown

Institutions: University of Florida Health, University of Florida, UF Health Cancer Center

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Epigenetic Silencing of ATM in Breast Cancer, Nitrosourea-induced growth arrest and apoptotic pathways

OpenAlex ID: W2105398225

FWCI: 4.109

Cites: 46

Cited by: 102

Related to: 10